Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | RECQL | P46063 | 3/20 | 0.61 |
| ▸ | CASP1 | P29466 | 3/20 | 0.61 |
| ▸ | THRB | P10828 | 2/20 | 0.61 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | APEX1 | P27695 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | TNF | P01375 | 1/20 | 0.61 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29783490 | 1.00 | ALDH1A1 (0.61) | ALDH1A1KDM4ECYP3A4MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL3473422 | 0.98 | MEN1 (0.64) | ALDH1A1KDM4ECYP3A4MEN1KMT2A | |
| Acetamide SCHEMBL27554773 | 0.94 | ALDH1A1 (0.55) | ALDH1A1KDM4ECYP3A4MEN1KMT2A | |
| SCHEMBL2892591 | 0.91 | ALDH1A1 (0.52) | ALDH1A1KDM4ECYP3A4MEN1KMT2A | |
| SCHEMBL2314690 | 0.83 | ALDH1A1 (0.50) | ALDH1A1KDM4ECYP3A4MEN1KMT2A | |
| SCHEMBL328278 | 0.83 | CASP1 (0.50) | ALDH1A1KDM4ECYP3A4MEN1KMT2A | |
| SCHEMBL99201 | 0.83 | ALDH1A1 (0.61) | ALDH1A1KDM4ECYP3A4MEN1KMT2A | |
| SCHEMBL6866812 | 0.82 | MCL1 (0.49) | ALDH1A1KDM4ECYP3A4MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL10592050 | 0.81 | MAPT (0.59) | ALDH1A1KDM4ECYP3A4MEN1KMT2A | |
| SCHEMBL27825872 | 0.80 | ALDH1A1 (0.44) | ALDH1A1KDM4ECYP3A4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115260478-A | Preparation method and application of high-strength high-toughness polylactic acid copolymer | 绍兴文理学院 | 2022-11-01 | — | — | CN | claimed |
| CN-110551280-B | Liquid crystal polymer, preparation method thereof and flexible printed circuit board prepared from liquid crystal polymer | Nanjing Qingyan Polymer New Materials Co.,Ltd. (CN) | 2021-08-31 | — | — | CN | claimed |
| CN-110551280-A | Liquid crystal polymer, preparation method thereof and flexible printed circuit board prepared from liquid crystal polymer | NANJING QINGYAN POLYMER NEW MAT CO LTD | 2019-12-10 | — | — | CN | claimed |
| CN-107619407-B | Bis- target spot inhibitor of HDAC and VEGFR based on pazopanib structure and its preparation method and application | 山东大学 | 2019-05-24 | — | — | CN | claimed |
| CN-107619407-A | Double target spot inhibitor of HDAC and VEGFR based on pazopanib structure and its preparation method and application | 山东大学 | 2018-01-23 | — | — | CN | claimed |
| CN-101768265-A | Modified nylon and preparation method thereof | UNIV SUZHOU | 2010-07-07 | — | — | CN | claimed |
| US-5757408-A | PRINTING IMAGE ON SUBSTRATE COATED WITH AMINO-ACID DERIVATIVE ADDITIVE; QUICK DRYING OF INK, OPTICAL DENSITY, NONCURLING | XEROX CORPORATION (US) | 1998-05-26 | — | — | US | claimed |
| US-5683793-A | Ink jet transparencies | XEROX CORPORATION (US) | 1997-11-04 | — | — | US | claimed |
| US-5589277-A | INK JET PRINTING, AQUEOUS INKS, FAST DRYING | XEROX CORPORATION (US) | 1996-12-31 | — | — | US | claimed |
| EP-0667246-A1 | Recording sheets containing amino acids, hydroxy acids, and polycarboxyl compounds | XEROX CORPORATION (US) | 1995-08-16 | — | — | EP | claimed |
| WO-2026107422-A1 | 6-(PYRIDIN-4-YL)-1H-BENZO[D]IMIDAZOLE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-4371987-B9 | SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS AS HPK1 INHIBITORS | GILEAD SCIENCES INC (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-4371987-B1 | SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS AS HPK1 INHIBITORS | GILEAD SCIENCES INC (US) | 2025-09-17 | — | — | EP | disclosed |
| US-12391647-B2 | Benzamide compound and preparation method, use, and pharmaceutical composition thereof | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2025-08-19 | — | — | US | disclosed |
| EP-4598582-A1 | PROTEOLYSIS-TARGETING CHIMERAS AGAINST THE PAPAIN-LIKE PROTEASE OF SARS-COV-2 | Tocris Cookson Limited (GB) | 2025-08-13 | — | — | EP | disclosed |
| WO-1984002136-A2 | POLYESTERS CONTAINING COPOLYMERIZED, ANTHRAQUINONE COLORANT COMPOUNDS CONTAINING SULFONAMIDO GROUPS | EASTMAN KODAK CO (US) | 1984-06-07 | — | — | WO | disclosed |
| US-4403092-A | COLORFAST FOOD CONTAINERS | EASTMAN KODAK COMPANY (US) | 1983-09-06 | — | — | US | disclosed |
| US-4269966-A | A MIXTURE OF AN ACRYLIC COMPOUND CONTAINING IMIDE, AMIDE, AND AN AMINE GROUP; MOLDING MATERIAL; CROSSLINKED, INSOLUBLE, INFUSIBLE POLYMER | TECHNOCHEMIE GMBH VERFAHRENSTECHNIK (DE) | 1981-05-26 | — | — | US | disclosed |
| US-4239883-A | INFUSIBLE AND INSOLUBLE | TECHNOCHEMIE GMBH VERFAHRENSTECHNIK (DE) | 1980-12-16 | — | — | US | disclosed |
| US-4165329-A | CARBOXYLATED UREA METAL SALTS | CHEVRON RESEARCH COMPANY (US) | 1979-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12391647-B2 | Benzamide compound and preparation method, use, and pharmaceutical composition thereof | JAK2, STAT3, STAT5A | ALDH1A1 635/4885KDM4E 1559/4885CYP3A4 1357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.